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Abstract Three groups of Rap1-specific guanine nucleotide
exchange factors including C3G, CalDAG-GEFI, and Epac/
cAMP-GEFI/II have been identified to date. In the present
study, we report a new Rap1 guanine nucleotide exchange factor
which we have named GFR (guanine nucleotide exchange factor
for Rap1). GFR shows close sequence similarity to EPAC/
cAMP-GEFI/II although GFR lacks a cAMP binding domain
and contains a nuclear localization signal. We demonstrated that
GFR can activate Rap1 but not H-Ras in 293T cells and that the
cdc25 domain of GFR is required for the activation of Rap1.
Northern blot analysis suggested that GFR mRNA is strongly
expressed in the brain. In transfected HeLa cells, GFR has been
found to be localized in the nuclei.
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1. Introduction
Ras family GTPases play a crucial role in cell growth, dif-
ferentiation and malignant transformation [1]. Rap1, a Ras
family small GTPase, was originally identi¢ed as an anti-on-
cogenic protein which e⁄ciently reverses the morphologic
transformation of the v-Ki-ras-expressing NIH 3T3 cell line,
DT [2]. Because the e¡ector domain of Rap1 was virtually
identical to that of Ras, it was suggested that Rap1 inhibits
the e¡ect of Ras through the formation of an inactivated
complex with the e¡ector proteins of Ras [3]. Consistent
with this model, the activation of the c-fos promoter from
Ras, but not from the activated Raf-1 which is an immediate
downstream e¡ector protein of Ras, is antagonized by the
expression of Rap1 [4]. In general, overexpression of Rap1
suppresses Ras signaling.
Rap1 is, however, not always activated by the extracellular
stimuli which counteract Ras. Rather, a number of stimuli
which may induce cell growth or di¡erentiation, such as T
cell receptor and B cell receptor activation, thrombin, epider-
mal growth factor, nerve growth factor, platelet-derived
growth factor, cAMP, calcium ionophore, and phorbol 12-
myristate 13-acetate (TPA), can activate Rap1 [5]. For exam-
ple, although Ras is critical for the neuronal di¡erentiation of
PC12 cells [6], cAMP [7] and nerve growth factor (NGF) [8]
induce neuronal di¡erentiation of PC12 cells through the ac-
tivation of Rap1. The exact mechanism by which these stimuli
activate Rap1 is largely unknown. However, it has become
clear that three groups of Rap1-speci¢c guanine nucleotide
exhange factors (GEFs), C3G [9,10], CalDAG-GEFI [11],
and Epac/cAMP-GEFI/II [12,13] are di¡erently implicated
in Rap1 activation. C3G associates with CrkL and Cbl in
response to T cell antigen receptor stimulation, resulting in
Rap1 activation and T cell anergy [14]. C3G can also bind to
Crk and Grb2, which are adapter proteins recruited to recep-
tor tyrosine kinases in response to growth factor stimulation
[15]. Thus, it is plausible that the C3G/Rap1 cascade might be
coupled to mitogenic signals. CalDAG-GEFI contains calci-
um or diacylglycerol (DAG) binding motifs and calcium ion-
ophore or TPA increases its catalytic activity for Rap1 in
293T cells [11]. Recent reports demonstrated that direct bind-
ing of cAMP to Epac/cAMP-GEFI/II can induce the catalytic
activity for Rap1 both in vivo and in vitro [12,13].
Here, we report a new member of Rap1-speci¢c GEF,
which we call GFR (guanine nucleotide exchange factor for
Rap1). GFR has signi¢cant sequence similarity to Epac/
cAMP-GEFI/II, although GFR itself lacks a cAMP binding
motif and contains a nuclear localization signal (NLS). GFR
is strongly expressed in the brain and localizes in nuclei when
transfected in HeLa cells.
2. Materials and methods
2.1. Cell culture and transfection
Human 293T embryonic kidney cells and human cervical carcinoma
HeLa cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(Nissui, Tokyo) supplemented with 10% fetal calf serum. 293T cells
and HeLa cells were transiently transfected by Superfect transfection
reagent (Qiagen).
2.2. Expression plasmids
Human GFR cDNA, originally reported as KIAA0277 (accession
number D87467) [16], was kindly provided by N. Nomura (Kazusa
Institute, Japan). The authentic GFR and the cDNA fragment lacking
the cdc25 domain of GFR (amino acids 1^315) were subcloned into
the pCXN2 eukaryotic expression vector after the addition of a Flag
tag sequence to its amino-terminus. The resulting vectors were desig-
nated pCXN2-Flag-GFR and pCXN2-Flag-GFRdCD. pEBG-Rap1
and pEBG-H-Ras encoded Rap1 and H-Ras fused to glutathione S-
transferase (GST) [17], respectively.
2.3. Antibodies
Anti-Flag antibody (M5) was obtained from Sigma. FITC-labeled
goat anti-mouse IgG antibody (F-2761) was purchased from Molec-
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Fig. 1. Features of the GFR gene. A: Predicted amino acid sequence of GFR and domains obtained from the PROSITE search are boxed. a,
LTE/rasGRF-associated domain. b, Cdc25 domain. The potential bipartite nuclear localization signal is underlined. B: Multiple sequence align-
ments of the amino-terminal region of GFR and EPAC/cAMP-GEFI/II (black indicates identity). C: Multiple sequence alignments of the
cdc25 domain of GFR, EPAC/cAMP-GEFI/II, human C3G, and mouse SOS (black indicates identity).
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ular Probes. Anti-GST rabbit antibody was kindly provided by Dr. S.
Matsufuji (Jikei University, Japan).
2.4. Sequence analysis
On-line BLAST searches were performed via the National Center
for Biotechnology Information at the National Institute of Health,
Bethesda, MD, USA. Protein alignments were carried out with the
DNASIS program (Hitachi Corporation). The Pro¢le Scan Output
service (PROSITE program) was used to search for protein motifs.
2.5. Northern blot analysis
DNA fragments containing the authentic GFR or L-actin cDNA
were labeled with the Multiprime DNA labeling system (Amersham).
A multi-tissue Northern blot (Clontech Laboratories) was hybridized
with 32Pi-labeled probes of GFR cDNA or L-actin cDNA and ana-
lyzed with a PhosphorImager, BAS2000 (Fuji Film).
2.6. Analysis of guanine nucleotide exchange activity of GFR for Rap1
and H-Ras in human 293T cells
Guanine nucleotides bound to Rap1 were analyzed essentially as
described previously [10]. Brie£y, 105 293T cells plated on 3.8 cm2
dishes were transfected with 2 Wg of expression plasmids. Forty-eight
hours after transfection, cells were labeled for 2 h with 0.05 mCi of
32Pi in 0.2 ml of phosphate-free medium. GST-fused Rap1 was col-
lected by glutathione-Sepharose 4B (Pharmacia). Guanine nucleotides
bound to Rap1 were separated by thin-layer chromatography and
quantitated with a PhosphorImager analyzer, FLA2000 (Fuji Film).
For the analysis of protein expression, cells were similarly processed
without isotopic labeling. The cleared lysates were separated by SDS-
PAGE, transferred to a nylon membrane, probed with anti-Flag or
anti-GST antibodies, and detected using the ECL chemiluminescence
system (Amersham).
2.7. Immuno£uorescence
HeLa cells transfected with pCXN2-Flag-GFR were ¢xed with 4%
paraformaldehyde in phosphate-bu¡ered saline supplemented with
30% sucrose for 15 min at 37‡C and permeabilized with 0.3% Triton
X-100 for 3 min. After blocking with 1% bovine serum albumin, the
cells were incubated with the anti-Flag antibody at a dilution of
1:100. The FITC-conjugated goat anti-mouse IgG at a dilution of
1:200 was used for the detection of Flag-tagged GFR, followed by
DNA staining by 4P,6-diamidine-2P-phenylindole dihydrochloride
(DAPI) (Boehringer Mannheim). The cells were viewed using a Carl
Zeiss £uorescence microscope.
3. Results
3.1. Identi¢cation and features of GFR cDNA
To identify a potential Rap1 GEF, we performed a BLAST
homology search using the cdc25 domain of C3G. The cdc25
domain is common to Ras family GEFs and mediates guanine
nucleotide exchange activity [18]. We found that clone
KIAA0277 has high amino acid similarity and selected it for
biochemical analysis. Since KIAA0277 showed catalytic activ-
ity for Rap1 as described below, we renamed it GFR (guanine
nucleotide exchange factor for Rap1). The predicted molecu-
lar weight of GFR is 67 730 Da with a theoretical pI of 5.87.
The Pro¢le Scan Output shows that GFR contains an LTE/
rasGRF-associated domain, potential bipartite nuclear local-
ization signal [19,20], and a cdc25 domain (Fig. 1A).
From the BLAST sequence search results, we found that
GFR shares signi¢cant sequence similarity to EPAC/cAMP-
GEFI/II [12,13], which are Rap1 GEFs activated by cAMP,
although the open reading frame of GFR lacks a cAMP bind-
ing motif. The cdc25 domain of GFR also shows sequence
similarity to other members of Ras family GEFs including
C3G [9], and SOS [21] (Fig. 1C). Remarkably, in addition
to the cdc25 domain, EPAC/cAMP-GEFI/II displays close
similarity to the amino-terminal region of GFR which con-
tains the LTE1/rasGRF-associated domain (Fig. 1B).
3.2. Activation of Rap1 by GFR in 293T cells
293T cells were transfected with expression vectors encod-
ing Flag-tagged GFR, C3G, GST-tagged Rap1, and H-Ras.
After 48 h, guanine nucleotides bound to GST-Rap1 were
analyzed by thin-layer chromatography. As shown in Fig. 2,
the expression of GFR signi¢cantly increased the ratio of
GTP/(GDP+GTP) on Rap1. The extent of Rap1 activation
by GFR was comparable to that by C3G. Although mSOS
activated GST-H-Ras (data not shown), GFR did not in-
crease the ratio of GTP to GDP on GST-tagged H-Ras, sug-
gesting that it has a strict exchange activity for Rap1. The
same expression levels of GFR, Rap1, and H-Ras protein
were con¢rmed in each experiment (data not shown). To con-
¢rm that Rap1 activation was mediated by the catalytic ac-
tivity of GFR, we constructed a plasmid which lacks the
cdc25 domain of GFR and designated it GFRdCD. As ex-
pected, the expression of GFRdCD did not a¡ect the ratio of
guanine nucleotides bound to Rap1 (Fig. 3). From these re-
sults, we concluded that GFR is a novel guanine nucleotide
exchange factor for Rap1.
3.3. Northern blot analysis of GFR mRNA
Next, we investigated the tissue distribution of GFR
mRNA (Fig. 4). Consistent with the fact that GFR was orig-
inally identi¢ed from a brain cDNA library [16], GFR was
predominantly expressed in the brain, although to some ex-
tent, it was also expressed in the heart, spleen, kidney, liver,
placenta, and lung.
Fig. 2. GFR activates Rap1 in 293T cells. A: 293T cells were trans-
fected with the expression vectors encoding the bottom. After 48 h,
the transfected cells were labeled with 32Pi for 2 h. GST-tagged
GTPases were collected by glutathione-Sepharose from the cell ly-
sates. Guanine nucleotides bound to GTPases were analyzed by
thin-layer chromatography. B: The radioactivity of each spot was
measured by a PhosphorImager, and the ratio of GTP to
GTP+GDP was calculated. Mean values obtained from three sam-
ples are shown with the S.D.
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3.4. Nuclear localization of GFR in HeLa cells
HeLa cells were transfected with expression vector encoding
Flag-tagged GFR, and its cellular localization was probed
with FITC-labeled goat anti-mouse IgG and DNA staining
by DAPI. As shown in Fig. 5, GFR has been co-localized
with DAPI staining, suggesting its existence in the nucleus.
4. Discussion
We have characterized a novel GEF for Rap1 which we
have named GFR. GFR shares signi¢cant sequence similarity
to EPAC/cAMP-GEFI/II [12,13]. GFR is abundantly ex-
pressed in the brain, and it is also detected in the heart,
spleen, kidney, liver, placenta, and lung. In addition to a
cdc25 domain, GFR contains a LTE1/rasGRF-associated do-
main and a bipartite nuclear localization signal [19,20]. Con-
sistent with the existence of NLS, GFR localizes in nuclei
when transfected in HeLa cells.
The LTE1/rasGRF-associated domain, also called the Ras
exchange motif region, is common to Ras family GEFs and
may be critical for the stabilization of GEF structure [22].
Endogenous Rap1 is mainly localized at endocytic and lyso-
somal vesicles in the cytoplasm [23]. Probably, GFR might
have to migrate from the nucleus to the cytoplasm in response
to stimuli that activate the GFR-Rap1 pathway. Alterna-
tively, GFR might stimulate nuclear GTPases other than
Rap1.
The amino-terminal portion of GFR lacks a cAMP binding
domain which controls the catalytic activity of EPAC/cAMP-
GEFI/II. However, there is a possibility that this region may
control its catalytic activity. In the case of C3G, truncation or
tyrosine phosphorylation of the amino-terminal region can
enhance its catalytic activity [24].
Since GFR mRNA is strongly expressed in the brain, the
GFR/Rap1 cascade might be implicated in neuronal prolifer-
ation or di¡erentiation. PC12 rat adrenal medullary cells dif-
ferentiate into sympathetic neurons upon stimulation with
NGF or cAMP. Rap1 is activated immediately after this stim-
ulation and triggers B-Raf/ERK activation. This cascade
Fig. 5. Nuclear localization of GFR in HeLa cells. HeLa cells were
transfected with expression vector (pCXN2-Flag-GFR). After 48 h,
¢xed cells were incubated with anti-Flag antibody, followed with
FITC-conjugated anti-mouse IgG. Then, cells were probed with
DNA staining by DAPI and visualized by a £uorescence micro-
scope.
Fig. 4. Expression of GFR mRNA in di¡erent tissues. A human
multiple-tissue Northern blot (Clontech) was hybridized in separate
experiments with 32Pi-labeled GFR (upper panel) and L-actin (lower
panel) probes as described. Lanes contain 2 Wg of poly(A) RNA
from the indicated tissues with loading normalized to L-actin. RNA
size markers are shown in the left margin (upper panel), the GFR
transcript is indicated by an arrow (upper panel), and the L-actin
transcripts are shown in the lower panel (note the alternative L-actin
transcripts in the heart and skeletal muscle).
Fig. 3. Cdc25 domain of GFR is required for the activation of
Rap1 in 293T cells. A: 293T cells were transfected with pEBG-
Rap1 and the expression vectors encoding the bottom. After 48 h,
the transfected cells were labeled with 32Pi for 2 h. GST-tagged
Rap1 was collected by glutathione-Sepharose from the cell lysates.
Guanine nucleotides bound to Rap1 were analyzed by thin-layer
chromatography. B: The radioactivity of each spot was measured
by a PhosphorImager, and the ratio of GTP to GTP+GDP was cal-
culated. Mean values obtained from three samples are shown with
the S.D.
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seemed to be critical for neuronal di¡erentiation [7,8]. How-
ever, a recent report suggests that endogenous Rap1 displays
no activation on treatment with NGF [5]. To clarify the po-
tential role of GFR in neuronal di¡erentiation, the expression
of GFRdCD may be useful because it will block GFR-de-
pendent pathway(s) like the C3G mutant lacking a catalytic
domain [25].
Some GEFs couple with growth factors by binding to their
receptors either directly or indirectly upon stimulation [15].
Thus, isolation of GFR binding proteins may be useful to
determine GFR-speci¢c cascade(s). Furthermore, in analogy
with C3G, whose catalytic activity is enhanced by the expres-
sion of C3G binding proteins [17], it is possible that proteins
which associate with GFR may control its activity in vivo.
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